Advanced Metastatic Egfr Expressing Cancers clinical trials

Explore recruiting advanced metastatic egfr expressing cancers clinical trials.

Recruiting advanced metastatic egfr expressing cancers studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Metastatic Egfr Expressing Cancers trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2a Open Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of AFM24 in Combination with Atezolizumab in Patients with Selected Advanced/Metastatic EGFR-expressing Cancers

Poland, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Advanced Metastatic Egfr Expressing Cancers trials by city

Advanced Metastatic Egfr Expressing Cancers in Toronto Advanced Metastatic Egfr Expressing Cancers in Vancouver Advanced Metastatic Egfr Expressing Cancers in Montreal Advanced Metastatic Egfr Expressing Cancers in Calgary Advanced Metastatic Egfr Expressing Cancers in Edmonton Advanced Metastatic Egfr Expressing Cancers in Ottawa Advanced Metastatic Egfr Expressing Cancers in Winnipeg Advanced Metastatic Egfr Expressing Cancers in Quebec City Advanced Metastatic Egfr Expressing Cancers in Hamilton Advanced Metastatic Egfr Expressing Cancers in Kitchener Advanced Metastatic Egfr Expressing Cancers in London Advanced Metastatic Egfr Expressing Cancers in Halifax Advanced Metastatic Egfr Expressing Cancers in New York Advanced Metastatic Egfr Expressing Cancers in Los Angeles Advanced Metastatic Egfr Expressing Cancers in Chicago Advanced Metastatic Egfr Expressing Cancers in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease